Hospital Admission for Vasa Previa
Prophylactic hospitalization for vasa previa should be individualized starting at 30-32 weeks gestation, with the decision based on specific risk factors including multiple pregnancy, antenatal bleeding, threatened preterm labor, and cervical shortening on transvaginal ultrasound. 111
Evidence-Based Approach to Admission Timing
The RCOG Green-top Guideline (2019) explicitly states that routine hospitalization is not mandatory for all patients with vasa previa. Instead, admission decisions should be risk-stratified 111. This represents the highest quality guideline evidence available and directly addresses the critical balance between preventing catastrophic fetal hemorrhage (60% mortality if undiagnosed and ruptured) versus avoiding unnecessary maternal anxiety, prolonged hospitalization, and iatrogenic prematurity.
Key Clinical Decision Points:
Mandatory hospitalization criteria:
- Multiple pregnancy
- Any antenatal bleeding
- Signs of threatened preterm labor
- Cervical shortening on transvaginal ultrasound (particularly rapid shortening >1mm/week) 11
Outpatient management may be appropriate when:
- Singleton pregnancy
- Asymptomatic patient
- Stable cervical length measurements on serial transvaginal ultrasound
- No history of bleeding or contractions
- Reliable patient with immediate access to cesarean delivery 11
Important Nuances in the Evidence
The guideline acknowledges that the benefit of hospitalization in asymptomatic women remains unproven 11. A 2017 prospective population-based cohort study found no difference in perinatal outcomes between hospitalized and non-hospitalized patients with prenatally diagnosed vasa previa 11. Recent research from 2026 confirms that outpatient management achieves equivalent perinatal outcomes in appropriately selected patients 2.
However, this must be balanced against the reality that approximately 28-43% of prenatally diagnosed cases require emergent cesarean delivery, typically for vaginal bleeding 34. The purpose of hospitalization is to enable immediate cesarean delivery before membrane rupture occurs, as fetal exsanguination can happen rapidly (total fetal blood volume at term is only 80-100 ml/kg) 11.
Practical Management Algorithm
At 30-32 weeks gestation, assess:
Confirm vasa previa persistence with third-trimester ultrasound (essential to avoid unnecessary interventions) 111
Administer corticosteroids at 32 weeks regardless of admission decision (due to increased preterm delivery risk) 111
Evaluate risk factors:
- Multiple gestation → Admit
- Any bleeding → Admit
- Contractions/preterm labor → Admit
- Cervical shortening on ultrasound → Admit
- Singleton, asymptomatic, stable cervix → Consider outpatient with close surveillance
If outpatient management chosen:
- Serial cervical length monitoring (starting 26-28 weeks)
- Patient education on warning signs (bleeding, contractions, rupture of membranes)
- Immediate access to facility with cesarean capability
- Consider proximity to hospital in decision-making
Critical Pitfalls to Avoid
- Do not delay cesarean delivery if bleeding occurs while attempting to confirm diagnosis, especially if fetal wellbeing is compromised 111
- Do not assume vasa previa persists without third-trimester confirmation—approximately 6% resolve on repeat ultrasound 4
- Do not perform amniotomy or allow vaginal delivery in confirmed cases
- Do not rely solely on absence of symptoms—70% of hospitalized patients required transfer to labor and delivery for urgent issues 5
Delivery Timing
Plan cesarean delivery at 34-36 weeks gestation in asymptomatic women to balance avoiding membrane rupture against minimizing iatrogenic prematurity 111. If premature rupture of membranes or labor occurs at any viable gestational age, perform cesarean section without delay 111.
The evidence demonstrates that with prenatal diagnosis and appropriate management (whether inpatient or carefully selected outpatient), survival rates exceed 95% compared to 40% or less when undiagnosed 11.